From: Multizonal anogenital neoplasia in women: a cohort analysis
MZN At first visit (n=50) | |
Disease location | |
Site | Number of cases HSIL/cancer |
Cervical | 3 |
Vulval | 37 |
Vagina | 14 |
Anal | 34 |
Perianal | 40 |
Number of sites HSIL/cancer | N (%) |
Two sites | 27 (54) |
Three sites | 18 (36) |
Four sites | 5 (10) |
Five sites | 0 (0) |
MZN at follow-up (n=20) | |
Disease location | |
Site | Number of cases HSIL/cancer |
Cervical | 2 |
Vulval | 12 |
Vagina | 8 |
Anal | 13 |
Perianal | 13 |
Number of sites HSIL/cancer | N (%) |
Two sites | 13 (65) |
Three sites | 6 (30) |
Four sites | 1 (5) |
Five sites | 0 (0) |